Home / Insurance / Does Humana Cover Ozempic? Insurance Guide 2026
MC
Reviewed by Marcus Chen Updated February 20, 2026

Does Humana Cover Ozempic? Insurance Guide 2026

Bold opening

As a clinical pharmacist, I frequently field questions about insurance coverage for Ozempic, a once-weekly injectable GLP-1 receptor agonist approved for type 2 diabetes and, more recently, chronic weight management. With rising demand and costs—Ozempic can exceed $1,000 per month without insurance—understanding your plan’s coverage is critical. Humana, one of the largest Medicare Advantage and commercial insurers, has specific policies regarding Ozempic that vary by plan type, diagnosis, and formulary tier. This guide breaks down Humana’s 2026 coverage policies, cost-sharing details, and actionable steps if your prescription is denied.

Does Humana Cover Ozempic for Diabetes?

Humana generally covers Ozempic (semaglutide) for type 2 diabetes under its Medicare Advantage and commercial plans, but coverage depends on medical necessity and formulary placement. Ozempic is FDA-approved for improving glycemic control in adults with type 2 diabetes, and Humana aligns with this indication. However, it is typically classified as a Tier 3 or Tier 4 medication on Humana’s formularies, meaning higher copays or coinsurance compared to generic alternatives like metformin or sulfonylureas.

To qualify, patients usually need documented failure or intolerance to first-line therapies (e.g., metformin, SGLT2 inhibitors, or DPP-4 inhibitors). Humana’s clinical guidelines often require prior authorization, which may mandate proof of A1C levels ≥7.0% despite lifestyle modifications and other medications. For Medicare Advantage plans, Ozempic is covered under Part D, but beneficiaries may face the “donut hole” coverage gap, increasing out-of-pocket costs mid-year.

If Ozempic is prescribed off-label for prediabetes, Humana is less likely to cover it unless the patient meets specific risk criteria (e.g., obesity, cardiovascular disease). Always verify coverage with Humana’s formulary tool or customer service, as plan specifics vary by region and employer group.

Does Humana Cover Ozempic for Weight Loss?

Humana’s coverage of Ozempic for weight loss is limited and inconsistent. While Ozempic is not FDA-approved for obesity, its active ingredient, semaglutide, is approved at a higher dose (2.4 mg) as Wegovy for chronic weight management. Humana may cover Ozempic for weight loss only if the patient has type 2 diabetes and obesity (BMI ≥30 or ≥27 with weight-related comorbidities), but this is rare without prior authorization.

For non-diabetic patients, Humana typically denies coverage for Ozempic, citing lack of FDA approval for obesity. Instead, Humana may cover Wegovy or other GLP-1 agonists like Saxenda (liraglutide) if the patient meets criteria: BMI ≥30 or ≥27 with hypertension, dyslipidemia, or sleep apnea. Even then, prior authorization is required, and patients may need to demonstrate failure with lifestyle interventions (e.g., diet, exercise, or behavioral therapy) for 6–12 months.

Commercial plans are more likely to cover weight-loss medications than Medicare Advantage plans, which are restricted by CMS guidelines. If Ozempic is denied, patients can appeal with a letter of medical necessity from their provider, emphasizing comorbidities like cardiovascular risk or mobility limitations.

How Much Does Ozempic Cost With Humana?

The cost of Ozempic with Humana varies widely based on plan type, formulary tier, and pharmacy network. For Medicare Advantage Part D plans, Ozempic typically falls into Tier 3 or 4, with copays ranging from $45 to $100 per month or 25–33% coinsurance. During the coverage gap (“donut hole”), patients may pay up to 25% of the drug’s list price (~$250–$300/month) until catastrophic coverage kicks in.

For commercial plans, copays are often lower but still substantial. Humana’s employer-sponsored plans may charge $30–$75 per month for Ozempic, depending on whether the patient has met their deductible. Some plans require coinsurance (e.g., 20% of the drug’s cost), which can exceed $200/month. Using Humana’s preferred pharmacies (e.g., CVS, Walmart) or mail-order services can reduce costs by 10–20%.

Patients can lower expenses by applying for Novo Nordisk’s patient assistance program (PAP), which offers Ozempic at $25/month for eligible low-income individuals. Alternatively, coupons from GoodRx or SingleCare may provide discounts at non-preferred pharmacies. Always confirm costs using Humana’s online tool or by calling customer service, as prices fluctuate based on dosage (0.25 mg, 0.5 mg, 1 mg, or 2 mg).

Ozempic Prior Authorization for Humana

Humana requires prior authorization (PA) for Ozempic in nearly all cases, regardless of indication. The PA process ensures the medication is medically necessary and cost-effective. For type 2 diabetes, providers must submit documentation showing:

  1. A1C ≥7.0% despite adherence to lifestyle changes and at least one other antidiabetic medication (e.g., metformin, SGLT2 inhibitor).
  2. Contraindications or intolerance to preferred alternatives (e.g., GLP-1 agonists like Trulicity or DPP-4 inhibitors like Januvia).
  3. Clinical rationale for Ozempic over other GLP-1 agonists (e.g., once-weekly dosing, cardiovascular benefits).

For weight loss, the criteria are stricter. Humana may approve Ozempic only if the patient has:

  • Type 2 diabetes and BMI ≥30 or ≥27 with weight-related comorbidities (e.g., hypertension, sleep apnea).
  • Documented failure with non-pharmacologic interventions (e.g., diet, exercise, or behavioral therapy) for 6+ months.
  • A prescription for Wegovy (semaglutide 2.4 mg) if the primary goal is weight loss.

Providers submit PAs through Humana’s online portal or via fax. Approvals are typically valid for 6–12 months, after which reauthorization is required. Denials can be appealed with additional clinical evidence, such as progress notes or lab results.

How to Get Humana to Cover Ozempic

Securing Humana’s coverage for Ozempic requires a strategic approach. Start by verifying your plan’s formulary using Humana’s online tool or calling customer service (1-800-457-4708). If Ozempic is listed as a Tier 3 or 4 drug, ask about step therapy requirements (e.g., trying metformin first) or quantity limits (e.g., 1 pen per month).

Next, work with your provider to submit a prior authorization (PA) request. The PA should include:

  • A detailed medical history, including failed therapies and A1C levels (for diabetes) or BMI and comorbidities (for weight loss).
  • Documentation of lifestyle interventions (e.g., diet logs, exercise programs) if requesting Ozempic for obesity.
  • A letter of medical necessity explaining why Ozempic is the best option (e.g., cardiovascular benefits, once-weekly dosing).

If the PA is denied, request a peer-to-peer review with a Humana medical director. Providers can often overturn denials by emphasizing clinical nuances (e.g., patient’s needle phobia with daily injections). For Medicare Advantage plans, consider appealing to an Independent Review Entity (IRE) if internal appeals fail.

Finally, explore cost-saving options like Novo Nordisk’s PAP or manufacturer coupons if coverage is denied. Some patients switch to a Humana plan with better Ozempic coverage during open enrollment.

What to Do If Humana Denies Ozempic

If Humana denies coverage for Ozempic, don’t panic—denials can often be overturned with persistence. First, request a written denial letter from Humana, which outlines the reason (e.g., lack of medical necessity, step therapy requirements) and appeal instructions. Common denial reasons include:

  • Incomplete prior authorization (e.g., missing lab results or failed therapies).
  • Off-label use (e.g., Ozempic for weight loss without diabetes).
  • Formulary restrictions (e.g., preferred alternatives like Trulicity).

To appeal, your provider must submit a formal request within 60 days of the denial, including:

  • A letter of medical necessity detailing why Ozempic is essential (e.g., patient’s inability to tolerate other GLP-1 agonists).
  • Supporting documents like progress notes, lab results, or peer-reviewed studies (e.g., Ozempic’s cardiovascular benefits from the SUSTAIN-6 trial).
  • A statement addressing Humana’s specific denial reason (e.g., “Patient failed metformin due to gastrointestinal side effects”).

For Medicare Advantage plans, you can escalate the appeal to an Independent Review Entity (IRE) if Humana upholds the denial. Commercial plan appeals may require a third-party review by an external medical expert. If all else fails, consider switching to a Humana plan with better Ozempic coverage during open enrollment or exploring patient assistance programs.

Humana Alternatives If Ozempic Is Not Covered

If Humana denies Ozempic or the cost is prohibitive, several alternatives may be covered or more affordable. For type 2 diabetes, Humana’s preferred GLP-1 agonists include:

  • Trulicity (dulaglutide): Once-weekly injection, often Tier 2 or 3 on Humana’s formulary. Similar efficacy to Ozempic but may have higher copays.
  • Victoza (liraglutide): Daily injection, covered for diabetes and sometimes weight loss. Lower cost but less convenient than Ozempic.
  • Byetta (exenatide): Twice-daily injection, typically Tier 2. Less effective for weight loss but cheaper.

For weight loss, Humana may cover:

  • Wegovy (semaglutide 2.4 mg): FDA-approved for obesity, but prior authorization is strict. Often requires BMI ≥30 or ≥27 with comorbidities.
  • Saxenda (liraglutide): Daily injection for weight loss, covered if Ozempic is denied. Higher copays but similar mechanism.
  • Contrave (naltrexone/bupropion): Oral medication, often Tier 2. Less effective than GLP-1 agonists but more affordable.

Non-pharmacologic options include Humana’s wellness programs, which may offer discounts on weight-loss clinics or nutrition counseling. For uninsured or underinsured patients, Novo Nordisk’s PAP or GoodRx coupons can reduce Ozempic’s cost to $25–$100/month. Always consult your provider to ensure the alternative is clinically appropriate.

Frequently Asked Questions

Does Humana cover Ozempic for weight loss?

Humana rarely covers Ozempic for weight loss unless the patient has type 2 diabetes and obesity (BMI ≥30 or ≥27 with comorbidities). Even then, prior authorization is required, and Humana may prefer Wegovy or Saxenda. Off-label use for obesity without diabetes is typically denied.

How much is the Ozempic copay with Humana?

Copays for Ozempic with Humana range from $30 to $100/month for commercial plans and $45 to $100/month for Medicare Advantage plans. During the Part D coverage gap, patients may pay 25% of the drug’s list price (~$250–$300/month). Costs vary by plan, so check Humana’s formulary tool for specifics.

Can I appeal if Humana denies Ozempic?

Yes, you can appeal a Humana denial for Ozempic. Your provider must submit a formal appeal within 60 days, including a letter of medical necessity and supporting documents. For Medicare Advantage plans, you can escalate to an Independent Review Entity if internal appeals fail. Persistence often overturns denials.